Daiki Terajima

National Cancer Center Hospital East

Papers

1

Total Citations

5

H-Index

1

About

Daiki Terajima is a surgeon-researcher advancing the frontiers of minimally invasive gastric cancer surgery, with a focused expertise in the management of advanced gastric malignancies. His most cited work, a 2024 comparative study, rigorously evaluates the feasibility of laparoscopic and robot-assisted surgery for Borrmann type 4 gastric cancer—a notoriously aggressive and diffusely infiltrative subtype. By directly comparing these modern techniques against conventional open surgery, Terajima provides critical evidence that minimally invasive approaches can be safely applied even in these challenging cases, potentially reducing patient recovery times and surgical morbidity without compromising oncologic outcomes. Though early in its citation impact, this study addresses a significant gap in the literature, as Borrmann type 4 tumors have traditionally been considered poor candidates for minimally invasive resection. Terajima’s work is notable for its methodological rigor and its direct clinical relevance, offering surgeons a data-driven rationale to expand the use of advanced surgical platforms. His contributions are steadily shaping best practices in gastric cancer surgery, bridging the gap between technological innovation and complex oncologic care.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of laparoscopic/robot-assisted surgery for Borrmann type 4 gastric cancer: a comparison study with conventional open surgery
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: National Cancer Center Hospital East

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago